BioProcess International Europe May 8-11 at the RAI in Amsterdam, Booth 130

Meet and speak to our experts to learn how our BioPharma Lifecycle Management (BPLM) platform, Polar, eliminates repetitive manual tasks, enabling you to efficiently execute your processes while curating the data you need to accelerate time-to-market by tackling the biggest challenges in process design, optimization, scale-up and technology transfer. Tech transfer is a critical yet challenging element of drug development and manufacturing. Transferring product, process and equipment knowledge between R&D and manufacturing teams is complex, expensive and time-consuming, costing several million dollars and taking 18 to 30 months. 

To address the tech transfer challenges that can delay or inhibit successful process scale-up, there is a need to rethink how the process description is controlled from the very start of process development, through process characterization and optimization, and ultimately on to manufacturing. 

Hear Marc speak on May 11 at 9:50 about “Next-generation bioprocessing strategies to improve speed, cost and quality of tech transfer”

We will explore how taking a holistic perspective can address key pain points, such as process standardization, design consistency, compliance and communication between R&D and manufacturing teams. This approach, facilitated by a digital data backbone and analytics engine that shares data and knowledge across the BioPharma lifecycle, helps to control the creation and development of the process description, automate experiment generation, facilitate structured experimental execution, integrate DoE, and by using industry-standard formats, streamline the transfer of the process description to manufacturing.  

Learn how an innovative tech transfer approach can enable consistent and compliant processes, increase efficiency, reduce costs and revolutionize drug manufacturing in the pharmaceutical industry.